This document provides Wyeth's worldwide net revenue by product for the first quarter of 2008 compared to the first quarter of 2007. It shows revenue breakdowns by geographic region and major products. Overall, Wyeth's total revenue decreased 8.1% to $2.6 billion compared to $2.9 billion in the prior year period, with pharmaceutical revenue decreasing 9.3% and consumer healthcare revenue increasing 1.5%.

1. FINAL
WYETH
WORLDWIDE NET REVENUE BY PRODUCT
THREE MONTHS ENDED MARCH 31, 2008
(000's)
(UNAUDITED)
DOMESTIC INTERNATIONAL TOTAL
1ST QTR 1ST QTR DOLLAR PERCENT 1ST QTR 1ST QTR DOLLAR PERCENT 1ST QTR 1ST QTR DOLLAR PERCENT
Wyeth Pharmaceuticals 2008 2007 CHANGE CHANGE 2008 2007 CHANGE CHANGE 2008 2007 CHANGE CHANGE
EFFEXOR $ 690,229 $ 598,684 $ 91,545 15.3% 331,157 $ 292,341 $ 38,816 13.3% $ 1,021,386 $ 891,025 $ 130,361 14.6%
PREVNAR 282,095 300,448 (18,353) -6.1% 423,708 316,114 107,594 34.0% 705,803 616,562 89,241 14.5%
ENBREL - - - N/A 605,558 445,205 160,353 36.0% 605,558 445,205 160,353 36.0%
NUTRITIONALS 1,300 972 328 33.7% 409,905 345,731 64,174 18.6% 411,205 346,703 64,502 18.6%
ZOSYN/TAZOCIN 179,215 135,709 43,506 32.1% 162,741 145,357 17,384 12.0% 341,956 281,066 60,890 21.7%
PREMARIN FAMILY 249,889 218,711 31,178 14.3% 26,252 22,437 3,815 17.0% 276,141 241,148 34,993 14.5%
PROTONIX RX 83,336 474,098 (390,762) -82.4% - - - N/A 83,336 474,098 (390,762) -82.4%
PROTONIX GENERIC 75,828 - 75,828 N/A - - - N/A 75,828 - 75,828 N/A
BENEFIX 67,946 84,285 (16,339) -19.4% 82,043 13,817 68,226 493.8% 149,989 98,102 51,887 52.9%
CONTRACEPTIVES 9,508 9,910 (402) -4.1% 94,846 100,192 (5,346) -5.3% 104,354 110,102 (5,748) -5.2%
RAPAMUNE 47,674 46,887 787 1.7% 47,731 36,529 11,202 30.7% 95,405 83,416 11,989 14.4%
BMP-2 88,220 94,916 (6,696) -7.1% 3,162 2,070 1,092 52.8% 91,382 96,986 (5,604) -5.8%
REFACTO 16,181 16,365 (184) -1.1% 73,041 62,183 10,858 17.5% 89,222 78,548 10,674 13.6%
TYGACIL 27,504 18,824 8,680 46.1% 14,439 6,763 7,676 113.5% 41,943 25,587 16,356 63.9%
TORISEL 17,438 - 17,438 N/A 4,041 - 4,041 N/A 21,479 - 21,479 N/A
subtotal 1,836,363 1,999,809 (163,446) -8.2% 2,278,624 1,788,739 489,885 27.4% 4,114,987 3,788,548 326,439 8.6%
OTHER PHARMACEUTICALS 23,467 135,457 (111,990) -82.7% 251,304 253,435 (2,131) -0.8% 274,771 388,892 (114,121) -29.3%
ALLIANCE REVENUE 339,347 278,772 60,575 21.7% 29,688 25,196 4,492 17.8% 369,035 303,968 65,067 21.4%
TOTAL WYETH PHARMACEUTICALS $ 2,199,177 $ 2,414,038 $ (214,861) -8.9% $ 2,559,616 $ 2,067,370 $ 492,246 23.8% $ 4,758,793 $ 4,481,408 $ 277,385 6.2%
FORT DODGE 102,892 123,290 (20,398) -16.5% 173,756 152,601 21,155 13.9% 276,648 275,891 757 0.3%
TOTAL PHARMACEUTICALS $ 2,302,069 $ 2,537,328 $ (235,259) -9.3% $ 2,733,372 $ 2,219,971 $ 513,401 23.1% $ 5,035,441 $ 4,757,299 $ 278,142 5.8%
Wyeth Consumer Healthcare
CENTRUM $ 73,432 $ 65,436 $ 7,996 12.2% 114,437 $ 93,643 $ 20,794 22.2% $ 187,869 $ 159,079 $ 28,790 18.1%
ADVIL 119,702 115,263 4,439 3.9% 51,916 43,170 8,746 20.3% 171,618 158,433 13,185 8.3%
CALTRATE 15,139 14,169 970 6.8% 41,779 33,813 7,966 23.6% 56,918 47,982 8,936 18.6%
ROBITUSSIN 26,508 35,068 (8,560) -24.4% 15,477 13,893 1,584 11.4% 41,985 48,961 (6,976) -14.2%
PREPARATION H 22,251 20,119 2,132 10.6% 7,306 6,250 1,056 16.9% 29,557 26,369 3,188 12.1%
CHAPSTICK 17,544 19,260 (1,716) -8.9% 5,788 5,113 675 13.2% 23,332 24,373 (1,041) -4.3%
ADVIL COLD & SINUS 6,919 6,782 137 2.0% 13,251 11,145 2,106 18.9% 20,170 17,927 2,243 12.5%
OTHER 43,245 43,957 (712) -1.6% 100,514 84,306 16,208 19.2% 143,759 128,263 15,496 12.1%
TOTAL CONSUMER HEALTHCARE $ 324,740 $ 320,054 $ 4,686 1.5% $ 350,468 $ 291,333 $ 59,135 20.3% $ 675,208 $ 611,387 $ 63,821 10.4%
Wyeth
TOTAL PHARMACEUTICALS $ 2,302,069 $ 2,537,328 $ (235,259) -9.3% $ 2,733,372 $ 2,219,971 $ 513,401 23.1% $ 5,035,441 $ 4,757,299 $ 278,142 5.8%
TOTAL CONSUMER HEALTHCARE 324,740 320,054 4,686 1.5% 350,468 291,333 59,135 20.3% 675,208 611,387 63,821 10.4%
TOTAL WYETH $ 2,626,809 $ 2,857,382 $ (230,573) (8.1)% $ 3,083,840 $ 2,511,304 $ 572,536 22.8% $ 5,710,649 $ 5,368,686 $ 341,963 6.4%